EliasAIliadisMDFACC, FSCAI, RPVI
Cardiology • Voorhees, NJAdult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine
Associate Professor of Medicine, Cooper Medical School of Rowan Univ
Dr. Iliadis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Centennial Blvd
Building 2 Suite 202
Voorhees, NJ 08043Phone+1 856-325-6700Fax+1 856-325-6702
Education & Training
University of MichiganFellowship, Interventional Cardiology, 1998 - 1999
Rush University Medical CenterFellowship, Cardiovascular Disease, 1995 - 1998
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1992 - 1995
Rutgers Robert Wood Johnson Medical SchoolClass of 1992
Certifications & Licensure
DE State Medical License 2012 - 2025
NJ State Medical License 2002 - 2025
PA State Medical License 1993 - 2024
SC State Medical License 2004 - 2004
IL State Medical License 1995 - 1999
MI State Medical License 1998 - 1999- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Inside Jersey Magazine Top Doctors Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 10 citationsClinical predictors of 30-day cardiac events in patients with acute coronary syndrome at a community hospital.George M. Tadros, Timothy R. McConnell, G. Craig Wood, John M. Costello, Elias A. Iliadis
Southern Medical Journal. 2003-11-01 - 30 citationsEffect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).M.Ashequl Islam, James C. Blankenship, Craig Balog, Elias A. Iliadis, A. Michael Lincoff
The American Journal of Cardiology. 2002-11-01 - 46 citationsEffect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial.James C. Blankenship, Gudaye Tasissa, J.Conor O’Shea, Elias A. Iliadis, Fouad A Bachour
Journal of the American College of Cardiology. 2001-09-01
Press Mentions
Clinical Trials on Venous Care Presented at THE VEINS 2022October 31st, 2022- Late-Breaking Clinical Trial Presentations Announced for the VEINS and VIVA ConferenceSeptember 14th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
